The U. S. Senate has investigated Medtronic for writing and editing highly positive reports on its spine fusion procedure in peer-reviewed medical journals, as well as paying doctors millions to appear as authors.
Medtronic’s manipulation of its product called Infuse included removing health and safety concerns.
The payout to doctors is listed as $210 million.
“The Senate’s findings highlight problems that should have been reported at least a decade ago, said Ray Baker, MD, a Kirkland, Wash., pain specialist who served on an advisory panel to Medicare and Medicaid on Infuse.
“I am just sad this happened,” he said. “At every level when we thought, ‘that wouldn’t happen,’ it happened. The integrity of our scientific literature is our foundation. It’s what predicates our treatments.”
It calls into question all such scientific literature on which the public depends.
Powered by Facebook Comments